European Pharmaceutical Review

APRIL 17, 2023

A report on automation in the biopharma industr y has shown that the market is projected to grow at a compound annual growth rate (CAGR) of 5.7 Factors impacting the automation in the biopharma industry market The report found that 75 percent of pharmaceutical organisations want to use automated solutions more frequently.

Biopharma 90

Biopharma Manufacturing Pharmaceutical products Marketing 90

Pharmaceutical Technology

DECEMBER 20, 2022

Now, Pfizer will lead all the development, commercialisation activities as well as costs for the RSV therapeutic candidate in the regions. In 2020, LianBio and Pfizer partnered to develop and commercialise transformative pharmaceutical products in Greater China.

Biopharma 64

Biopharma Pharmaceutical products Patients Pharmaceutical 64

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] The food sector has already initiated the publication of preliminary regulations aimed at restricting PFAS in packaging. [3].

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

pharmaphorum

SEPTEMBER 28, 2022

In recent years, the biopharma market has become progressively complex. As a result, payers are feeling increased pressure to make the right decisions based on the perceived value of each product. HTA agencies can assist biopharma companies at the early stages of development to ensure they are meeting the expectations of payers.

Biopharma 52

Biopharma Side effects Consulting Pharmaceutical products 52